Statements (52)
Predicate | Object |
---|---|
gptkbp:instanceOf |
platform
|
gptkbp:aimsTo |
patient outcomes
time to market for drugs |
gptkbp:collaboratesWith |
academic institutions
|
gptkbp:developedBy |
gptkb:TARIS_Biomedical
|
gptkbp:enables |
personalized treatment plans
|
gptkbp:enhances |
therapeutic development
|
gptkbp:facilitates |
regulatory submissions
|
gptkbp:focusesOn |
precision medicine
|
gptkbp:hasRelatedPatent |
clinical trials
|
https://www.w3.org/2000/01/rdf-schema#label |
TARIS™ Platform
|
gptkbp:integratesWith |
clinical workflows
|
gptkbp:isAttendedBy |
healthcare_providers
|
gptkbp:isBasedOn |
advanced analytics
|
gptkbp:isCompatibleWith |
various sample types
|
gptkbp:isDesignedFor |
improve diagnostic accuracy
oncology applications |
gptkbp:isEnhancedBy |
machine learning
|
gptkbp:isEvaluatedBy |
clinical trials
clinical studies |
gptkbp:isFocusedOn |
early detection of diseases
improving patient care |
gptkbp:isIntegratedWith |
laboratory information systems
healthcare_systems |
gptkbp:isLinkedTo |
patient stratification
|
gptkbp:isPartOf |
biomedical research
biotechnology industry precision medicine initiatives the future of medicine |
gptkbp:isPromotedBy |
scientific publications
|
gptkbp:isPromotedThrough |
partnerships
|
gptkbp:isRecognizedBy |
gptkb:FDA
|
gptkbp:isRecognizedFor |
innovation in diagnostics
a leading platform in oncology |
gptkbp:isSupportedBy |
venture capital
scientific research clinical evidence |
gptkbp:isTargetedAt |
healthcare_professionals
|
gptkbp:isUsedIn |
diagnostic testing
|
gptkbp:isUtilizedFor |
pharmaceutical companies
treatment monitoring biomarker validation |
gptkbp:isUtilizedIn |
research collaborations
|
gptkbp:isVisitedBy |
cancer research
collaborative research efforts |
gptkbp:offers |
real-time data analysis
|
gptkbp:provides |
comprehensive reporting
analytical services |
gptkbp:providesAccessTo |
genomic data
|
gptkbp:supports |
biomarker_discovery
|
gptkbp:usedFor |
drug development
|
gptkbp:utilizes |
liquid biopsy technology
|